Diagnostics growth drives Zoetis' latest acquisitionFebruary 14, 2020Four months after venturing into the world of reference laboratory services, Zoetis has bolstered its presence within the space through the acquisition of Ethos Diagnostic Science.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started